Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography

American Journal of Psychiatry

Volumn 157, Issue 2, 2000, Pages 269-271

  Laakso, Aki ^b   Vilkman, Harry ^b   Alakare, Birgitta ^b   Haaparanta, Merja ^b   Bergman, Jörgen ^b   Solin, Olof ^b   Peurasaari, Jari ^b   Räkköläinen, Viljo ^b   Syvälahti, Erkka ^b   Hietala, Jarmo ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; DOPAMINE TRANSPORTER; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; FEMALE; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; BRAIN; CARRIER PROTEINS; CAUDATE NUCLEUS; COCAINE; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; FEMALE; FUNCTIONAL LATERALITY; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; SCHIZOPHRENIA; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033961748     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.157.2.269     Document Type: Article

References (8)

1. Hietala J, Syvälahti E, Vuorio K, Räkköläinen V, Bergman J, Haaparanta M, Solin O, Kuoppamäki M, Kirvelä O, Ruotsalainen U, Salokangas RKR: Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients. Lancet 1995; 346:1130-1131
2. Hietala J, Syvälahti E, Vilkman H, Vuorio K, Räkköläinen V, Bergman J, Haaparanta M, Solin O, Kuoppamäki M, Eronen E, Ruotsalainen U, Salokangas RKR: Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia. Schizophr Res 1999; 35:41-50
3. Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, D'Souza CD, Erdos J, McCance E, Rosenblatt W, Fingado C, Zoghbi SS, Baldwin RM, Seibyl JP, Krystal JH, Charney DS, Innis RB: Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA 1996; 93:9235-9240
4. Breier A, Su T-P, Saunders R, Carson RE, Kolachana BS, de Bartolomeis A, Weinberger DR, Weisenfeld N, Malhotra AK, Eckelman WC, Pickar D: Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci USA 1997; 94:2569-2574
5. Bannon MJ, Granneman JG, Kapatos G: The dopamine transporter: potential involvement in neuropsychiatric disorders, in Psychopharmacology: The Fourth Generation of Progress. Edited by Bloom FE, Kupfer DJ. New York, Raven Press, 1995, pp 179-188
6. 18F]WIN 35,428), a radioligand to study the dopamine transporter with PET: characterization in human subjects. Synapse 1998; 28:244-250
7. Kay SR, Fiszbein A, Opler LA: The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13:261-276
8. Parent A: Extrinsic connections of the basal ganglia. Trends Neurosci 1990; 13:254-258